Clinical Trial Update: Dopaminergic Therapy for Anhedonia - 2 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial conducted by Emory University is evaluating a dopaminergic therapy for anhedonia and depression, and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Emory University | Conditions: Anhedonia, Depression | Phase 4 | Status: RECRUITING